230 related articles for article (PubMed ID: 14991335)
1. Neurobiological basis for the use of botulinum toxin in pain therapy.
Mense S
J Neurol; 2004 Feb; 251 Suppl 1():I1-7. PubMed ID: 14991335
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin in the treatment of rare head and neck pain syndromes: a systematic review of the literature.
Sycha T; Kranz G; Auff E; Schnider P
J Neurol; 2004 Feb; 251 Suppl 1():I19-30. PubMed ID: 14991339
[TBL] [Abstract][Full Text] [Related]
3. [Muscarinic modulation of cardiac activity].
Sauviat MP
J Soc Biol; 1999; 193(6):469-80. PubMed ID: 10783705
[TBL] [Abstract][Full Text] [Related]
4. [Pathophysiology of low back pain and the transition to the chronic state - experimental data and new concepts].
Mense S
Schmerz; 2001 Dec; 15(6):413-7. PubMed ID: 11793144
[TBL] [Abstract][Full Text] [Related]
5. [Botulinum toxin for the treatment of pain syndromes].
Ferreira JJ; Couto M; Costa J; Coelho M; Rosa MM; Sampaio C
Acta Reumatol Port; 2006; 31(1):49-62. PubMed ID: 17058384
[TBL] [Abstract][Full Text] [Related]
6. The structure and mode of action of different botulinum toxins.
Dolly JO; Aoki KR
Eur J Neurol; 2006 Dec; 13 Suppl 4():1-9. PubMed ID: 17112344
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin (BoNT) and back pain.
Porta M; Maggioni G
J Neurol; 2004 Feb; 251 Suppl 1():I15-8. PubMed ID: 14991338
[TBL] [Abstract][Full Text] [Related]
8. Excitatory cholinergic and purinergic signaling in bladder are equally susceptible to botulinum neurotoxin a consistent with co-release of transmitters from efferent fibers.
Lawrence GW; Aoki KR; Dolly JO
J Pharmacol Exp Ther; 2010 Sep; 334(3):1080-6. PubMed ID: 20576797
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic uses of botulinum toxin.
Wheeler AH
Am Fam Physician; 1997 Feb; 55(2):541-5, 548. PubMed ID: 9054223
[TBL] [Abstract][Full Text] [Related]
10. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
11. The current use of botulinum toxin.
Mahant N; Clouston PD; Lorentz IT
J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
[TBL] [Abstract][Full Text] [Related]
12. Re-engineering clostridial neurotoxins for the treatment of chronic pain: current status and future prospects.
Pickett A
BioDrugs; 2010 Jun; 24(3):173-82. PubMed ID: 20462283
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxins for pain].
Soinila S; Haanpää M
Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
[TBL] [Abstract][Full Text] [Related]
14. Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins.
Dolly O
Headache; 2003; 43 Suppl 1():S16-24. PubMed ID: 12887390
[TBL] [Abstract][Full Text] [Related]
15. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.
Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B
Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945
[TBL] [Abstract][Full Text] [Related]
16. Presynaptic protein interactions in vivo: evidence from botulinum A, C, D and E action at frog neuromuscular junction.
Raciborska DA; Trimble WS; Charlton MP
Eur J Neurosci; 1998 Aug; 10(8):2617-28. PubMed ID: 9767392
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin in clinical practice.
Hughes AJ
Drugs; 1994 Dec; 48(6):888-93. PubMed ID: 7533696
[TBL] [Abstract][Full Text] [Related]
18. Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.
Luvisetto S; Gazerani P; Cianchetti C; Pavone F
Toxins (Basel); 2015 Sep; 7(9):3818-44. PubMed ID: 26404377
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin as a therapeutic agent.
Tsui JK
Pharmacol Ther; 1996; 72(1):13-24. PubMed ID: 8981568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
